Date: 04/01/2016
Whitman Walker Health’s Megan Coleman appeared on Good Morning Washington on Thursday, March 31, 2016 to talk about HIV Pre-Exposure Prophylaxis (PrEP)
Click HERE or on the photo to view the video.
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
